Sort   by:  
 Page size 
UnknownTBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.
Not available
S-EPMC4451173 | biostudies-literature
UnknownMulticenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.
Not available
S-EPMC6209089 | biostudies-literature
UnknownInherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Not available
S-EPMC4302212 | biostudies-literature
UnknownGermline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition.
Not available
S-EPMC9041070 | biostudies-literature
UnknownPrevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
Not available
S-EPMC9123503 | biostudies-literature
UnknownFactor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
Not available
S-EPMC2897879 | biostudies-literature
UnknownClonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes.
Not available
S-EPMC12424905 | biostudies-literature
UnknownClinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.
Not available
S-EPMC8770707 | biostudies-literature
UnknownUse of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC4224991 | biostudies-literature
UnknownInherited TP53 Variants and Risk of Prostate Cancer.
Not available
S-EPMC8891030 | biostudies-literature
Sort   by:  
 Page size